A new medication that combines an already approved drug with a new unapproved one has been shown to cut the level of LDL, or “bad” cholestero l, when statins aren’t helping enough. In the Phase 3 ...

There are many orally administered drugs which are very helpful in the right dosage, but quite harmful in larger amounts. A new microneedle patch is designed to help in that regard, by showing exactly ...

Did a drug testing laboratory eager to win a contract with the Horseracing Integrity and Safety Authority lower their levels of detection on some tests in 2022, causing Todd Pletcher-trained Forte to ...

Otsuka Pharmaceutical has shared more detailed data behind its kidney disease drug’s phase 3 win, showing the monoclonal antibody halved patients’ urine protein-to-creatinine ratio (UPCR) levels.